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Abstract 
Human T cell development within the thymus is a well-characterized event, and it is 
known that a functional thymus is required for normal T cell generation to take place. Individuals 
with poor thymic function, from either congenital abnormality or post-natal injury, have a 
difficult time mounting a proper immune response and suffer from debilitating immune 
deficiency. Thus, it would be highly beneficial to identify an extrathymic human tissue that can 
support T cell differentiation so that we may eventually augment T cell production in these 
individuals. However, to date, no definitive site of extrathymic T cell development has been 
established. In this study, we used flow cytometry to identify five populations of putative 
extrathymic T cell precursors within the human pediatric tonsil. These populations range from an 
early CD34+CD38dimLin- subset all the way to a CD1a+CD4+CD8+CD3+/- double positive pre-T 
cell. Each subset identified phenotypically resembles the same population found in the human 
thymus, suggesting that there is considerable similarity between the cells in each of these two 
tissues. Furthermore, each putative extrathymic T cell developmental intermediate found within 
the tonsil retains the ability to develop into a mature CD3+ T cell. Thus, our data suggest that the 
human tonsil contains a full spectrum of T cell developmental intermediates that are remarkably 
similar to those found in the human thymus, and that the tonsil may be an extrathymic site which 





Human hematopoiesis is the process whereby hematopoietic stem cells (HSCs) and 
progenitor cells (HPCs) give rise to all cells of the immune system. After birth HPCs within the 
thymus specifically give rise to T cells, critical mediators of the adaptive immune system1. 
Indeed, a functional thymus is necessary for the development of a complete T cell repertoire in a 
normal individual, and individuals sustaining thymic malformation or injury are prone to 
immune deficiency2. However, whether non-thymic tissues can support T cell development is 
currently unknown. Our laboratory has previously published that HPCs expressing CD34, a 
marker of immaturity, reside within the human tonsil and lymph node, and we have established 
that as a bulk population these cells have the ability to differentiate into T cells, natural killer 
cells, and dendritic cells in ex vivo assays3,4. These data suggest that it is possible that a 
hematopoietic progenitor cell capable of T cell differentiation seeds these secondary lymphoid 
tissues, but whether the tonsil or lymph node microenvironment can actually support full T cell 
development has yet to be established.  
Human T cell development takes place through a well-characterized set of cellular stages, 
each of which is defined by a unique expression of antigens on the cell surface1. Thymic T cell 
development begins with an immature cell called the Thymic Seeding Progenitor (TSP), which is 
phenotypically characterized as CD34+CD38dimLin-. This cell is a multipotent, highly replicative 
progenitor cell, and represents the first thymocyte which displays signs of T cell receptor (TCR) 
gene rearrangement1,5. Soon after entry into the thymus, the TSP increases the expression of 
CD38 on its surface, yielding a slightly more mature CD34+CD38brightLin- cell, which then gains 
acquisition of the marker CD1a. The resulting CD34+CD1a+ population, known as a pre-T cell, is 
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the first thymic subset to show signs of developmental commitment to the T cell lineage1. Next, 
the thymocyte loses the expression of CD34 as it increases the expression of CD4 and CD8 on its 
cell surface, to form what is ultimately known as the CD4+CD8+ double positive (DP) pre-T cell. 
The DP cell expresses CD1a, is committed to the T cell lineage, and begins to express variable 
levels of the T cell specific marker CD31. Upon acquisition of CD3, the thymocyte 
downregulates expression of either CD4 or CD8 and begins to express a functional T cell 
receptor to become a single positive naïve T cell1.  
While this process has been well defined in the thymus, whether or not it can take place 
extrathymically is currently unknown. The question of whether or not extrathymic tissues can 
and do support T cell development is clinically significant.  Should a secondary lymphoid tissue 
be able to host complete T cell differentiation, it is possible that future methods could be 
developed to augment and enhance this phenomenon in the situation of poor thymic function. 
Thus, this study sought out to establish if the human tonsil does contain a pathway of 
extrathymic T cell development in normal physiological conditions.  
Results and Discussion 
In this study, we obtained fresh human tonsils from pediatric elective tonsillectomy 
patients and used flow cytometry to investigate whether or not the bulk population of tonsillar 
cells contains extrathymic T cell precursors. A single cell suspension was made from human 
tonsillar cells, and the resulting mononuclear fraction was enriched for cells expressing the 
marker CD34. Within the CD34-enriched tonsillar subset, we first identified a CD34+CD38dim 
and a CD34+CD38bright population neither of which expresses markers specific to any mature 
human hematopoietic lineage (Lin-) (Figure 1A). Phenotypically, these cells resemble the thymic 
seeding progenitor and the more mature downstream CD34+CD38brightLin- cells identified in the 
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thymus. Thus, this data suggested that perhaps the human tonsil contains early precursor cells, 
which resemble those of the human thymus.  
Next, we sought to determine if the tonsil contains pre-T cells similar to those found in 
the thymus. CD34-enriched tonsillar cells were analyzed for the expression of CD1a, which is 
found on both pre-T cells1 and on antigen presenting cells (APCs)6,7. Within the total CD34+ 
subset, the tonsil contains a small but consistent population of CD34+CD1a+ cells, which upon 
further analysis, expresses either CD10 or CD11c (Figure 1B). As CD10 is consistently found on 
thymic CD34+CD1a+ pre-T cells1, and CD11c is a marker APCs  that is not found on thymic pre-
T cells (data not sown), we hypothesize that the CD34+CD1a+CD10+CD11c- fraction of the 
human tonsil represents an extrathymic pre-T cell, whereas the similarly identified population 
expressing CD11c, may be a distinct lineage altogether.  
The data presented in Figure 1 highly suggests that the earliest stages of T cell 
development, including a CD34+CD38dimLin- multipotent progenitor, a CD34+CD38brightLin- 
precursor, and a CD34+CD1a+CD11c- pre-T cell may reside within the human tonsil. To further 
establish whether or not this is true, we examined the expression of more than 25 human 
hematopoietic markers on the surface of these three subsets from both the tonsil and the thymus 
Total mononuclear cells from each tissue were enriched for CD34-expressing cells, and flow 
cytometry was used to gate on the CD34+CD38dimLin-, CD34+CD38brightLin-, or 
CD34+CD1a+CD11c- subsets from each tissue (Figure 2A-B).  
The CD34+CD38dimLin- and CD34+CD38brightLin tonsillar subsets shared many 
phenotypic characteristics with those from the thymus. For example, The CD34+CD38dimLin- 
subsets from the tonsil and the thymus were similar in that both express CD10, low levels of 
CD25, CD33, CD45RA, and HLA-DR, and lack expression of CD4, CD8, CD56, and CD116. 
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Similarly, Similarly, CD34+CD38brightLin- cells from both the tonsil and the thymus express 
CD2, CD10, and CD45RA, but lack expression of CD4, CD8, CD56, and CD116. However, 
these two subsets from the tonsil also demonstrate some differences from their thymic 
counterparts as seen in Figure 2. It is possible that these differences reflect that different 
progenitor cells seed the tonsil and the thymus, or alternatively that the microenvironment of 
each tissue differently effects the phenotype of the same progenitor upon its entry into either the 
tonsil or thymus. Future studies should address this issue.  
Intriguingly, the CD34+CD1a+CD11c- populations from both the tonsil and the thymus 
are remarkably similar in phenotype. Both express CD2, CD7, CD5, CD10, CD127, and 
intracellular TdT. Similarly, both lack expression of CD8, CD25, CD116, CD56, CD33, and 
HLA-DR (Figure 2A-B). Importantly, a lack of CD116, CD33, and HLA-DR further confirms 
that this subset from the tonsil likely does not represent a cell that is part of an antigen presenting 
lineage. Furthermore, CD34+CD1a+CD11c- cells from both the thymus and the tonsil express 
variable levels of CD4, indicating that each is transitioning to an early CD4+ single positive cell, 
typically seen at this stage of thymic development1. Overall, the data presented in Figure 2 
suggest that the human tonsil contains early precursor cells that appear similar in phenotype to 
the first three stages of human T cell development, and that this extrathymic tissue is capable of 
supporting at least the earliest steps of T cell differentiation.  
 To establish if the human tonsil contains T cell developmental intermediates beyond 
these early CD34+ precursors, we next sought to identify CD34- pre-T cells. In the thymus, 
CD34+CD1a+ pre-T cells lose CD34 as they increase the expression of CD4, CD8 and eventually 
CD3 on their surface, all the while retaining CD1a expression1. Thus, we used flow cytometry to 
examine the relationship of CD34, CD1a, and CD3 in the tonsil to see if a complete spectrum of 
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these populations may reside within this tissue. To do so, we simultaneously enriched CD19-
depleted tonsillar cells for cells expressing CD34, CD1a, or a combination of these two markers.. 
The relationship between CD34, CD3, and CD1a suggests that as in the thymus, tonsillar 
CD1a+CD11c- cells can be divided between those that express CD34, those that express neither 
CD3 nor CD34, and those that express CD3 (Figure 3). This is in line with a model wherein cells 
progress from a CD34-expressing precursor to a more mature CD34-CD3- pre-T cell and finally 
to a more mature CD3+ naïve T cell.  
To further examine whether or not CD34-CD1a+CD3+/= tonsillar cells represent true 
extrathymic T cell precursors, we examined three CD34-CD11c- populations in both the tonsil 
and the thymus for the expression of T cell-associated antigens: CD34-CD1a+CD3-CD11c- cells, 
CD34-CD1a+CD3+CD11c- cells, and CD34-CD1a-CD3+CD11c- cells (Figure 4A-B). In both 
tissues, as the cells progressed from CD1a+CD3- to CD1a+CD3+ and then to CD1a-CD3+, there 
was a consistent decrease in expression of the early T cell proteins TdT and CD10, but an 
increase in the expression of the mature T cell markers CD5, CD7 and in T cell receptors. 
Interestingly, in both tissues, a large majority of CD34-CD1a+CD3-CD11c- cells expressed both 
CD4 and CD8 (Figure 4A-B), indicating that these cells likely represent the true CD4+CD8+ DP 
cells that are so well characterized in human thymic T cell differentiation.  
The phenotypic data presented thus far suggests that five populations of putative 
extrathymic T cell precursors reside within the human tonsil: 1) CD34+CD38dimLin-; 2) 
CD34+CD38brightLin-; 3) CD34+CD1a+CD3-; 4) CD34-CD1a+CD3-; and 5) CD34-CD1a+CD3+ 
cells (Figure 5A). To verify that each population identified could differentiate into mature T 
cells, we used fluorescence activated cell sorting (FACS) to isolate each subset to purity. As a 
control, we also sorted CD34-CD1a-CD3+ cells (Population 6; Figure 5A), which represent the 
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majority of mature CD3+ T cells in the tonsil. We then tested their T cell differentiation 
capabilities in a well established ex vivo culture system, wherein each population was cultured in 
the presence of OP9-DL1 cells and the cytokines Flt3 Ligand (FL) and Interleukin-7 (IL-7). 
Furthermore, we performed the same experiments from these six populations isolated from the 
human thymus for comparison. All six populations from both the tonsil and the thymus retained 
T cell developmental potential, as evidenced by the emergence of CD3+ T cells that expressed 
variable levels of CD4, CD8, and T cell receptors on their surface after 26 days (Figure 5B-C). 
These data suggest that the five populations identified in this study have T cell potential, and that 
the tonsil contains a full spectrum of extrathymic T cell developmental intermediates similar to 
those found in the human thymus.  
In summary, our phenotypic and differentiation data suggest that the human tonsil 
contains a spectrum of T cell developmental intermediates beginning with a CD34+CD38dim 
hematopoietic progenitor cell which progresses to a CD34+ pre-T cell and later a CD34-
CD1a+CD4+CD8+CD3+/- T cell precursor. The identification of the tonsil as a site for 
extrathymic T cell development challenges the paradigm that the thymus is the only organ 
responsible for complete T cell genesis, and raises the possibility that other lymphoid organs 
could support T cell differentiation in the situation of poor thymic function resulting from injury 
or disease.  
Experimental Procedures 
Human Cell Isolation: Human tonsils and thymuses were obtained from pediatric donors 
at Nationwide Children’s Hospital (Columbus, OH) under the approval of the Ohio State 
University Institutional Review Board and according to the guidelines set forth by the 
Declaration of Helsinksi. Single cell suspensions were made from both tonsils and thymuses by 
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manual homogenization and passing through a 70 µm mesh strainer. Total mononuclear cells 
were then obtained via density centrifugation on Ficoll-Paque Plus. To enrich tonsillar tissue for 
total CD34+ cells, CD3+ T and CD19+ B cells were first depleted from the mononuclear cell 
fraction using magnetic microbead separation (Miltenyi Biotec). The resulting fractions were 
then enriched for CD34-expressing cells using an indirect CD34 isolation kit (Miltenyi Biotec). 
To enrich tonsillar cells for CD34 and CD1a-expressing cells, CD19+ B cells were magnetically 
depleted from the total mononuclear cell pool, and the resulting cells were then simultaneously 
subjected to CD34 and CD1a magnetic enrichment (Miltenyi Biotec). Human thymic 
mononuclear cells were enriched for CD34-expressing cells using an indirect CD34 isolation kit 
(Miltenyi Biotec).  
Flow cytometry and cell sorting: All fluorescently labeled antibodies used were 
purchased from BD Biosciences, Beckman Coulter, or Mitlenyi Biotec. Intracellular staining for 
TdT was performed after surface staining using the BD Cytofix/Cytoperm Plus 
fixation/permeabilization kit (BD Biosciences) according to the manufacturer’s 
recommendations. Flow cytometry was performed on a FACS Vantage (BD Biosciences) or LSR 
II (BD Biosciences), and data was analyzed using FlowJo software (Treestar, Inc). Cell sorting 
of T cell precursors from the thymus or tonsil was performed on a FACS Aria (BD Biosciences). 
Purity assessments routinely revealed that sorted populations were >95% pure.  
T cell differentiation Assays: T cell differentiation assays were performed in flat-bottom 
96 well plates in the presence of OP9-DL1 stromal cells (a gift from J.C. Zúñiga-Pflücker, 
University of Toronto, Toronto, Canada), 100 ng/ml Flt3 ligand (FL), 10 ng/ml IL-7 (Miltenyi 
Biotec), and α-MEM plus L-glutamine (Gibco) supplemented with 20% fetal bovine serum, 
penicillin G (100 µg/ml) and streptomycin (100 µg/ml) (Gibco). Cultures were initiated with a 
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starting cell density of 450-5,000 hematopoietic precursor cells per well. Every 7-9 days, cells 
were disrupted, passed through a 70 µm cell strainer, and were deposited on new stromal cells 
with fresh cytokine-supplemented medium. In between these cell transfers, one half of the 





Figure 1: The human tonsil contains CD34+CD38dimLin-, CD34+CD38brightLin-, and 
CD34+CD1a+CD11c- cells. CD19 and CD3-depleted tonsil cells were magnetically enriched for 
CD34-expressing cells. (A) Expression of CD34 and the lineage markers CD11c, BDCA-2, 
CD117, CD161, CD19, CD3 and CD1a (Lin) on CD34 enriched tonsillar cells (left). Total 
lymphocytes were gated on Lin- events and analyzed for their expression of CD34 and CD38 
(right).  The two rectangles illustrate the relative differences in CD34 surface density for the 
CD34+CD38dim (“dim”) and CD34+CD38bright (“bright”) subsets.  (B) Expression of CD1a on 
CD34 enriched tonsillar cells (left). Events were gated on CD34+CD1a+ cells and analyzed for 
their co-expression of CD10 and CD11c (right).. All data are from a representative tonsil of >10 



































Figure 2: Phenotypic comparison of CD34+CD38dimLin-, CD34+CD38brightLin-, and 
CD34+CD1a+CD11c- cells in human tonsil and thymus. (A) Tonsillar mononuclear cells were 
magnetically depleted of CD3 and CD19 expressing cells, and were then enriched for CD34+ 
cells. Enriched cells are gated on CD34+CD38dimLin- (left), CD34+CD38brightLin- (middle), or 
CD34+CD1a+CD11c- (right) events. (B) Thymic mononuclear cells were magnetically enriched 
for CD34+ cells and then gated on the same three populations as in (A). Data for each antigen is 















Figure 3: The relationship between CD34, CD1a, and CD3 within the human tonsil. CD19-
depleted tonsillar cells were simultaneously enriched for both CD34 and CD1a-expressing cells.  
Enriched cells were gated on CD11c- (left) or CD34-CD11c- (right) events and analyzed for 
expression of CD34 and CD1a (left), and CD3 and CD1a (right). Thymic CD34+ and CD34- cells 
were similarly analyzed after CD34 magnetic selection. Data are from representative donors, and 




Figure 4: Putative extrathymic T cell precursors in the human tonsil acquire T cell 
associatedantigens in a fashion similar to those in the thymus. (A) CD1a-enriched tonsillar cells 
were gated on CD34-11c- events and analyzed for the expression of T cell-associated antigens on 
three populations: CD1a+CD3-; CD1a+CD3+; and CD1a-CD3- (B) CD34-depleted thymic cells 
were gated on the same three populations and analyzed as in (A). Data are from representative 
donors, and each analysis was performed in three independent tonsils or two independent 
thymuses. In each histogram, filled lines indicate staining with the indicated antibody, whereas 




































Figure 5: T cell differentiation potential of six putative extrathymic T cell precursors in the 
human tonsil. (A) Tonsillar mononuclear cells were depleted of CD19+ events, enriched for 
CD34+ and CD1a+ cells, and the six populations shown were isolated using FACS. (B) All six 
populations were cultured independently on OP9-DL1 cells with FL and IL-7 for 26 days. After 
harvest, cells were analyzed for the expression of CD3, CD4, CD8, TCRαβ, and TCRγδ. Data 
Figure 5 
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are gated on GFP-CD45+ events to exclude OP9-DL1 stromal cells from analysis. (C) Thymus 
mononuclear cells were magnetically enriched for CD34+ events. Populations 1-3 were sorted 
from the CD34+ fraction, and populations 4-6 were sorted from the CD34- fraction. Each 
population was cultured on OP9-DL1 cells with FL and IL-7 for 26 days. After harvest, cells 
were analyzed as in (B). Data shown is representative of 3 experiments performed with 
individual tonsil donors (B) or of 2 experiments performed with individual thymus donors (C). 
Numbers represent the mean percentages of GFP-CD45+ cells which stained double positive for 
both antigens indicated on the dot plot. 
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